Background and Aims
Endoscopic sleeve gastroplasty (ESG) is an incisionless, transoral, restrictive bariatric
procedure designed to imitate sleeve gastrectomy (SG). Comparative studies and large-scale
population-based data are limited. Additionally, no studies have examined the impact
of race on outcomes after ESG. This study aims to compare short-term outcomes of ESG
with SG and evaluate racial effects on short-term outcomes after ESG.
Methods
We retrospectively analyzed over 600,000 patients in the Metabolic and Bariatric Surgery
Accreditation and Quality Improvement Program database from 2016 to 2020. We compared
occurrences of adverse events (AEs), readmissions, reoperations, and reinterventions
within 30 days after procedures. Multivariate regression evaluated the impact of patient
factors, including race, on AEs.
Results
A total of 6054 patients underwent ESG and 597,463 underwent SG. AEs were low after
both procedures with no significant difference in major AEs (SG vs ESG: 1.1% vs 1.4%;
P > .05). However, patients undergoing ESG had more readmissions (3.8% vs 2.6%), reoperations
(1.4% vs .8%), and reinterventions (2.8% vs .7%) within 30 days (P < .05). Race was not significantly associated with AEs after ESG, with black race
associated with a higher risk of AEs in SG.
Conclusions
ESG demonstrates a comparable major AE rate with SG. Race did not impact short-term
AEs after ESG. Further prospective studies long-term studies are needed to compare
ESG with SG.
Abbreviations:
AE (adverse event), BMI (body mass index), ESG (endoscopic sleeve gastroplasty), MBSAQIP (Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program), SG (sleeve gastrectomy)To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Projected U.S. state-level prevalence of adult obesity and severe obesity.N Engl J Med. 2019; 381: 2440-2450
- Health effects of overweight and obesity in 195 countries over 25 years.N Engl J Med. 2017; 377: 13-27
- Bariatric and metabolic endoscopy: impact on obesity and related comorbidities.Therap Adv Gastrointest Endosc. 2021;
American Society of Metabolic and Bariatric Surgery. Estimate of bariatric surgery numbers, 2011-2019. Available at: https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers. Accessed August 19, 2022.
- Predictors of surgical intervention for those seeking bariatric surgery.Surg Obes Relat Dis. 2021; 17: 1558-1565
- Changes in utilization of bariatric surgery in the United States from 1993 to 2016.Ann Surg. 2020; 271: 201-209
- Overview of bariatric and metabolic endoscopy interventions.Ther Adv Gastrointest Endosc. 2020; 13
- Outcomes of endoscopic sleeve gastroplasty: How does it compare to laparoscopic sleeve gastrectomy? A systematic review and meta-analysis.Endosc Int Open. 2020; 08
- Systematic review and meta-analysis of endoscopic sleeve gastroplasty with comparison to laparoscopic sleeve gastrectomy.Obes Surg. 2020; 30: 2754-2762
- Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study.Gastrointest Endosc. 2019; 89: 782-788
- endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a meta-analysis.Am J Gastroenterol. 2019; : 114
- Laparoscopic sleeve gastrectomy versus endoscopic sleeve gastroplasty: a systematic review and meta-analysis.Endosc Int Open. 2021; 9 ([published correction appears in Endosc Int Open 2021 Jan;9(1):C1]): E87-E95
- Inequity to the utilization of bariatric surgery: a systematic review and meta-analysis.Obes Surg. 2015; 25: 888-899
- Racial disparity in 30-day outcomes of metabolic and bariatric surgery.Obes Surg. 2020; 30: 1011-1020
- Racial disparities in perioperative outcomes after bariatric surgery.Surg Obes Relat Dis. 2019; 15: 786-793
- MBSAQIP participant use data file (PUF). American College of Surgeons.(Available at:) (Accessed August 19, 2022)
- 6-Month gastrointestinal quality of life (QOL) results after endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a propensity score analysis.Obes Surg. 2020; 30: 1944-1951
- Endoscopic sleeve gastroplasty (ESG) for morbid obesity: How effective is it?.Surg Endosc. 2022; 36: 352-360
- Fifth International Consensus Conference: current status of sleeve gastrectomy.Surg Obes Relat Dis. 2016; 12: 750-756
- Racial disparities in bariatric surgery complications and mortality using the MBSAQIP data registry.Obes Surg. 2020; 30: 3099-3110
- Racial disparities in perioperative outcomes after metabolic and bariatric surgery: a case-control matched study.Surg Obes Relat Dis. 2020; 16: 1111-1123
Article info
Publication history
Published online: July 20, 2022
Accepted:
July 13,
2022
Received:
May 2,
2022
Footnotes
DISCLOSURE: The following author disclosed financial relationships: V. M. Shami: Consultant for Olympus Medical and Cook Medical. All other authors disclosed no financial relationships.
Identification
Copyright
© 2023 by the American Society for Gastrointestinal Endoscopy
